The effect of oral contraceptives (OC) containing a combination of ethinyloestradiol (EE2) and either desogestrel (Dg/EE2) or levonorgestrel (Lg/EE2) on plasma concentrations of sex hormone binding globulin (SHBG), total testosterone (T), free T, total androstenedione (A), free A and on salivary T and A concentrations have been studied. SHBG concentrations were higher in the Dg/EE2 group than in the Lg/EE2 group. Total T, measured by RIA with prior extraction and chromatography, is also higher in the Dg/EE2 group.
Oral contraceptive (OC) combinations containing the progestagen desogestrel (Dg) and the oestrogen ethinyloestradiol (EE2) have been reported to induce higher serum levels of sex hormone binding globulin (SHBG) than combinations of EE2 with levonorgestrel (Lg). This difference has been interpreted as a selective androgenic'r" or anti-oestrogenic" action of Lg on the oestrogen-induced SHBG-rise, which Dg does not possess. In addition, lower plasma free testosterone (Fl') values were found during administration of Dg/EE2 than with Lg/EE2." 3. 4 We studied the effect of both OC's on plasma free and salivary androgens. In comparable studies, I 'direct' assays (i.e. without prior extraction and chromatography) for the measure-Correspondence: L Swinkels. Department of Experimental and Chemical Endocrinology. St Radboud University Hospital. P.O. Box 9)()I, Nijmcgen, the Netherlands. 354 ment of total testosterone (T) concentrations were used. The validity of these assays relies mainly on the specificity of the antibody and on the efficacy of added inhibitors of steroid binding to plasma proteins such as SHBG. 7 Total T concentrations in this study were measured by RIA following extraction and chromatography. The results are compared with total T concentrations as assessed by such a commercial 'direct' assay.
As the per cent free androstenedione (A) concentration is relatively high (about 9%), free A can conveniently be assessed by equilibrium dialysis. provided that chromatographically pure tracer is employed. In contrast to free A, the non-protein bound fraction ofT (IT). or per cent free T. is very small. Especially in the case of a small free fraction, in equilibrium dialysis radiochemical impurities will lead to spuriously elevated free fractions. For this reason free T was determined by symmetric dialysis (SYD). a method which is much less affected by tracer contamlnation.v!" Like many other steroids. testosterone (T) is also detectable in saliva. As it is assumed that salivary steroids derive largely from the plasma non-protein bound moiety. it was thought of interest to investigate whether the differences in FT are reflected in the salivary T (ST). Since ST could partly be derived from metabolism of A during transfer through the salivarygland. II. 12 we measured A both in plasma and saliva.
Materials and methods

SUBJECTS AND SAMPLING
All subjects in this study were healthy female volunteers. aged between 18 and 45 years. Of these subjects 23 women used an OC. containing 3() !J.g EE2 and ISO !J.g Dg, for at least 6 months (Group II). Another 23 received 30 !J.g EE2 and 150 !J.g Lg for the same period of time (Group III). Whole saliva and blood samples were taken between 8.(XI and 9.lXl a.m. on the l Sth day of the pill cycle (groups II and III). Also. a set of samples was obtained on the 18th day of the menstrual cycle of 22 subjects who used no OC or other medications (Group IL).
Saliva flow was stimulated by applying citric acid to the tongue. Prior to assay saliva samples were sonicated using an MSE Soniprep ISO. All samples were stored at -20"C until analysis.
RA DIOIMMUNOASSA Y T and A concentrations were estimated by RIA involving diethylether-extraction and paper chromatography in a Bush A system (petroleum-ether. b.p. 80"-1H)OC: methanol: water. 9:7:4. by vol). Aliquots of I mL of plasma or 3 mL of saliva were assayed using [I. 2. 6. 7. 3Hl-testosterone. specific activity 102 Ci/mmol) and [1.2. 6. 7-3H)-androstenedione. specific activity 8S Ci/mmol). Anti-T antiserum was raised in rabbits against testosterone-Ilhemisuccinate conjugated to albumin (antibody titre I:5()()(). Anti-A antiserum was raised in rabbits against androstenedione-19-carboxymethyloxime conjugated to albumin (titre I :5()(KI).
The lower limit of detection for the T assay was 3·S pmoVL (I fmol per tube). The within batch coefficient of variation was 4'Yo over a range of concentrations from 0·1 to 35 nmoVL. For the A assay the lower limit of detection was 12 pmol/L (about 3·5 fmoVtube). The coefficient of variation was 6% over a range of concentrations from ()'2 to 8·5 nmol/L.
DIRECT RADIOIMMUNOASSAY OF T
For the 'direct' measurement of T we employed a 'direct testosterone e 25 I)' radioimmunoassay kit (Farmos Diagnostica, Farmos Group Ltd, Oulunsalo, Finland).
SUBG ASSAY
Plasma SHBG was estimated using a suspended solid phase immunoradiometric assay (IRMA) kit (Farmos Diagnostica, Farmos Group Ltd. Oulunsalo, Finland).
DIALYSIS
Microtype dialysis cells (working volume 2xO·2 mL, membrane area 2 cm 2 • Diachema AG Switzerland) were rotated at a constant speed (20 rpm) in a water bath kept at 37·O"C. Visking dialysis membranes (exclusion limit 8000-15000 daltons) were washed in distilled water and soaked in 0·01 M phosphate buffered saline (0·9"10, pH 7·4) (PBS).
ASSESSMENT OF FREE A. EQUILIBRIUM DIALYSIS
Undiluted plasma samples (300 !J.L) were incubated with 30 000 dpm of [3H]-A. The tritiated A was purified by paper chromatography in a modified Bush A system (see above). An aliquot of 180 !J.L of the incubate was pipetted in one cell half and dialysed against 180 !J.L of PBS. For the measurement of the total radioactivity 50 !J.L of the incubate was counted in duplicate.
The free fraction of A was calculated according to the formula: f'O=1/(CO/C2-VtlVO+1) where: f'O=estimate of the free fraction of the undiluted sample; CO=the concentration of radioactivity in the original sample; C2=the concentration of radioactivity in the dialysate; Vt=the total volume in the dialysis system; VO=the original sample volume; Multiplication of f'O by total A yields the estimate of the concentration of free A of the undiluted sample.
ASSESSMENT OF FREE T; SYMMETRIC DIALYSIS
Symmetric dialysis (SYD) differs essentially from equilibrium dialysis in that the plasma sample is present on both sides of the dialysis membrane. Moreover, the rate at which the radiolabelled hormone migrates from one compartment to the opposite one, rather than the tracer distribution at equilibrium, serves as a measure of the free hormone fraction. The measurement of IT by SYD was performed as described previously. 10 The system was calibrated using plasma samples in which IT was measured by equilibrium dialysis followed by RIA for T in the dialysate.
In each assay the dialysis rate of a reference sample with a known IT was measured in quadruplicate. Aliquots of 500 ul, of plasma were incubated with 20 ()(X) dpm [3H]-T for 30 min at 37°C. In temperature equilibrated cells 180 ilL of the incubate was pipetted in one compartment. The other compartment was filled with 180 ul, of the same plasma without [3H]-T. Undiluted samples were dialysed at 37°C for 5 h. The intra-assay coefficient of variation from duplicates was 2·8%. The interassay coefficient of variation was 5·0%.
STATISTICAL ANALYSIS
Student's r-test was used to compare differences between means of populations.
Results
The plasma concentration of SHBG is significantly higher (P<O·()()l) in women using DglEE2 (Group II. 184±67 nmol/L, mean±SD) than in subjects receiving LglEE2 (Group III. 65±20 nmoIlL). Both mean concentrations are higher than in Group IL (46'6± 19·4 nmollL) (Fig. I) .
The total concentration of T in the OCgroups is significantly higher than (Group II). or equal to (Group III) the total T concentration in Group IL).
The plasma per cent free T is inversely correlated (r=O·772. P<O·OOI. n=68) to the concentration of SHBG. and thus is lowest in Group II.
There is no difference in FT concentrations between Group II and III. However. FT in both OC-groups is lower than the mean level in the luteal phase (IL: 9·1±3·5 pmol/L; II: 4·2±1·8 pmollL and III: 4·9±2·5 pmol/L). The same holds for plasma free A (FA) concentrations.
Plasma total T concentrations were also measured by 'direct' RIA (Farmos Diagnostica) in Groups II and III. Mean levels were higher (Group II: 1·95± HB nmoltL and Group III 1·54±0·95 nmollL) than those obtained by RIA following extraction and chromatography (Group II: 1·45±0·42 nmollL and Group III O·84±O·44 nmoIlL). Moreover. there is no significant difference between these two mean total T concentrations. The mean Ff concentration in Groups II and III. that were equal when calculated using total T obtained after extraction and chromatography. now become different using the 'direct' total T (Group II: 6·02±4·35 pmoVL and Group III 9·03±5·4 nmol/L, P<0'05; Fig. 2 ).
total T nM r n s.-, TABLE 1 . Differences between salivary to serum free ratios ofT and A (mean±SD) in women treated with DglEE2 (II, n=23). LglEE2 (Ill, n=23) and in non-treated subjects (IL. n=22)
In contrast to Fr. there is no significant difference in the salivary concentration of T (ST) between the three groups. Salivary A concentrations are (SA) lower (P<0·05) in Group 1II than in controls ( Fig. 1) . Salivary T concentrations are much higher than the Fl' concentrations in all groups (Table  1) . Nevertheless, ST and Ff correlated significantly within each group (IL: r=0·622, P<O'Ol; II: r=0·524. P<O·OI and III: r=O·846, P<O·OOI). The SA/FA ratio does not differ from unity in Group II. but was significantly less than 1·0 in Groups IL and II (P<O·OOI, Table 1 ). SA is highly correlated with plasma FA (IL: r=0·960, P<O'OOI; II: r=0·847, P<O'OOl; III: r=0·911. P<O·OOl). (III n=23) . Free T was calculated from the per cent free T. and total T as assessed by either total T assay.
Discussion
Administration of EE2 induced elevated levels of SHBG. The progestagenic components (e.g. Lg) of some OC's more or less completely counteract the oestrogen-induced rise of SHBG. The synthetic progestagen Dg,-or rather its active metabolite 3-keto-Dg-, has been reported to lack this so-called androgenic'r" or 'anti-oestrogenic" effect with respect to its effect on SHBG. OC combinations of EE2 with Dg lead to SHBG levels that are comparable to those obtained with EE2 alone. I. 4. 13 It has been suggested': 2. 13 that the higher available SHBG binding capacity for T and other androgens will lead to lower plasma free levels than in untreated subjects or subjects using LglEE2. Indeed, lower plasma free T has been reported by Hammond. 1 This observation has been taken as a possible explanation for the reported improvement of existing acne and hirsutism." 5. 13 The present study confirms earlier observations concerning SHBG levels during treatment with DglEEZ and LglEEZ. The impressive rise in SHBG in the DglEEZ group was absent in the LglEEZ group. However, there were no differences in Ff or in ST between the DglEEZ and LglEEZ group. Moreover, ST in both OC groups did not differ from ST in the control group.
In contrast with other reports': 3. 4. 13. 14 the total T concentration as estimated by RIA following extraction and chromatography, was found to be higher in the DglEEZ group than in the LglEEZ group. The results for total T concentrations using the direct assay were similar to those found by Hammond, I employing the same kit for the assessment of total T. Using these results to calculate Ff from the per cent free T (which are comparable to those found by Hammond), consequently, yielded a lower Ff in the DglEEZ group than in the LglEEZ group. The discrepancy between both types of assay for total T in our view is connected to the SHBG content of the sample as the relative difference in the total T concentration for each sample, as estimated by both types of assay, is correlated with the concentration of SHBG (P<O·Ol).
The concentrations of steroids in saliva are usually similar to those of the corresponding non-protein bound moiety in plasma." This suggests that salivary steroid levels derive directly from the plasma free steroid. However, in the present study ST concentrations were three times higher than Ff concentrations in controls and about seven times higher than in either of the OC groups. The difference between ST and Ff concentrations cannot be explained by the recently reported occurrence of minute amounts to SHBG and albumin in saliva, as these would account only for an elevation of IO-Z0% with respect to Ff.IC> Moreover, SA concentrations are not higher than FA concentrations.
It must be concluded that T either accumulates in saliva by some unknown mechanism, or that it is at least for a large part synthesized in the salivary gland which may be considered as a 'non-conventional androgen responsive structure'. I? Synthesis in the salivary gland from A is a likely mechanism II. 12 as the presence of 17-0H steroid oxidoreductase. required for this transition. has been demonstrated.P The high ST concentrations in the OC-groups are not likely to be induced by increased conversion of A. since FA and SA concentrations in these groups were lower than normal. However. T could accumulate as a result of decreased 5-alpha-reductase activity. Both oestrogens'" and progestagens'" have been reported to reduce 5-alpha-reductase activity.
In this study. no differences in the plasma free or salivary concentration of T and A between either OC group could be demonstrated. The reported lack of androgenic or anti-oestrogenic action of desogestrel is more likely thus to reflect the relatively low binding affinity of 3-keto-Dg for the androgen receptor."
The use of 'direct' assays for the assessment of total concentrations of steroid hormones in plasma. especially when comparing groups with different levels of binding proteins. should be discouraged.
Steroid hormone measurement in saliva is a potentially attractive alternative. or at least a useful adjunct, to (free) hormone assay in plasma for assessment of the endocrine status. The comparison of salivary and plasma free levels of steroid hormones could provide some insight into metabolism in the salivary gland.
